In this issue:
- Modifiable risk factors for CVD and all-cause mortality
- Multivessel immediate vs staged revascularisation in acute STEMI
- Optical coherence tomography-guided vs angiography-guided PCI
- Rosuvastatin vs atorvastatin in adults with coronary artery disease
- Orthostatic hypotension, hypertension treatment, and CVD
- BP levels in late adolescence and future risk of cardiovascular events
- 10-year cardiovascular risk in patients with newly diagnosed T2DM
- Lipid-lowering therapy for primary prevention in older adults
- Efficacy of a traditional Chinese medicine in patients with STEMI
- Semaglutide and cardiovascular outcomes in obesity without diabetes
Please login below to download this issue (PDF)